FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, authorizing changes to the approved ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Hypertension with Left Ventricular Hypertrophy

Drugs mentioned

• Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)